Jasper Brinckmann-Hesebeck
Ulm, BW, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Multiplex Panel Detects Glial and Inflammatory Biomarker Signatures in Sporadic and C9orf72-ALS.
Journal: Neurology(R) neuroimmunology & neuroinflammation
Published: July 16, 2026
Deep clinical, genetic, and serum biomarker profiling indicates glial and neuronal pathology in primary brain calcification.
Journal: Brain communications
Published: December 12, 2024
Non-motor symptoms in patients with amyotrophic lateral sclerosis: current state and future directions.
Journal: Journal of neurology
Published: April 17, 2024
Clinical and patient-reported outcomes and neurofilament response during tofersen treatment in SOD1-related ALS-A multicenter observational study over 18 months.
Journal: Muscle & nerve
Published: January 19, 2024
Tofersen decreases neurofilament levels supporting the pathogenesis of the SOD1 p.D91A variant in amyotrophic lateral sclerosis patients.
Journal: Communications medicine
Published: January 14, 2024
Effects of tofersen treatment in patients with SOD1-ALS in a "real-world" setting - a 12-month multicenter cohort study from the German early access program.
Journal: EClinicalMedicine
Published: November 06, 2023
Showing 1-8 of 8
Last Updated: 09/26/2026